Receptor antagonist
Class of pharmacological agents, which reduces or diminishes the effect of an agonist on a receptor
A receptor antagonist is a type of receptor ligand or drug that blocks or dampens a biological response by binding to and blocking a receptor rather than activating it like an agonist. Antagonist drugs interfere in the natural operation of receptor proteins.
Nº Q410943 ★★
Uncommon · Knowledge
Receptor antagonist
Class of pharmacological agents, which reduces or diminishes the effect of an agonist on a receptor
A receptor antagonist is a type of receptor ligand or drug that blocks or dampens a biological response by binding to and blocking a receptor rather than activating it like an agonist. Antagonist drugs interfere in the natural operation of receptor proteins.
Last price
—
Floor price
—
7-day median
—
30-day sales
0
30-day range
—
In circulation
0
Price history
median
low – high
sales
No sales in this period
Show table
| Date | median | Low | High | sales |
|---|
Sales history
- Last sale
- —
- 30-day average
- —
- 30-day low
- —
- 30-day high
- —
- Sales 7d
- 0
- Sales 30d
- 0
No sales yet.
Anonymous sales: no buyer or seller shown. Figures count player-to-player sales only.
From Wikipedia
A receptor antagonist is a type of receptor ligand or drug that blocks or dampens a biological response by binding to and blocking a receptor rather than activating it like an agonist. Antagonist drugs interfere in the natural operation of receptor proteins. They are sometimes called blockers; examples include alpha blockers, beta blockers, and calcium channel blockers. In pharmacology, antagonists have affinity but no efficacy for their cognate receptors, and binding will disrupt the interaction and inhibit the function of an agonist or inverse agonist at receptors. Antagonists mediate their effects by binding to the active site or to the allosteric site on a receptor, or they may interact at unique binding sites not normally involved in the biological regulation of the receptor's activity. Antagonist activity may be reversible or irreversible depending on the longevity of the antagonist–receptor complex, which, in turn, depends on the nature of antagonist–receptor binding. The majority of drug antagonists achieve their potency by competing with endogenous ligands or substrates at structurally defined binding sites on receptors.
Text: Wikipédia, CC BY-SA 4.0. · Image: JWSchmidt at English Wikipedia (CC BY-SA 3.0) ·
Related cards
Alpha blocker
Class of pharmacological agents
Nº Q1927838 ★★★
Antagonism (chemistry)
Situation in which two chemicals upon interaction interfere in such a way that the action of one partially or completely inhibits the effects of the other
Nº Q4770891 ★★★
Adrenergic agonist
Drug that stimulates a response from the adrenergic receptors
Nº Q2496749 ★★
Alpha-adrenergic agonist
Drugs that selectively bind to and activate alpha adrenergic receptors
Nº Q4734924 ★
Angiotensin II receptor blocker
Group of pharmaceuticals that modulate the renin–angiotensin system
Nº Q285044 ★★
Receptor (biochemistry)
Protein molecule receiving signals for a cell
Nº Q208467 ★★